Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-06 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | -26,45k | 353,08k | Verkauf | 13,35 | 0,00 | -100,00% |
| 2026-03-31 | Ms. Juliana Papa DrinaneHead of Manufacturing & Supply | 10,82k | 0,00 | Derivative Exercise and Retained Stock | - | 33,24k | 48,24% |
| 2026-03-31 | Ms. Juliana Papa DrinaneHead of Manufacturing & Supply | -5,64k | 32,13k | Derivative Exercise and Sale | 5,70 | 33,24k | - |
| 2026-03-31 | Dr. Juan Camilo Arjona FerreiraExec. VP, Head of Research & Development and Chief Medical Officer | -4,82k | 27,47k | Derivative Exercise and Sale | 5,70 | 30,05k | - |
| 2026-03-31 | Dr. Juan Camilo Arjona FerreiraExec. VP, Head of Research & Development and Chief Medical Officer | 8,61k | 0,00 | Derivative Exercise and Retained Stock | - | 30,05k | 40,17% |
| 2026-03-31 | Mr. Daniel KarpChief Strategy Officer & Head of Corporate Development | -5,66k | 32,26k | Derivative Exercise and Sale | 5,70 | 69,55k | - |
| 2026-03-31 | Mr. Daniel KarpChief Strategy Officer & Head of Corporate Development | 12,39k | 0,00 | Derivative Exercise and Retained Stock | - | 69,55k | 21,69% |
| 2026-03-31 | Ms. Rachel A. StahlerExec. VP, Chief Information Officer and Chief Digital & Growth Officer | 12,40k | 0,00 | Derivative Exercise and Retained Stock | - | 116,11k | 11,96% |
| 2026-03-31 | Ms. Rachel A. StahlerExec. VP, Chief Information Officer and Chief Digital & Growth Officer | -6,46k | 36,84k | Derivative Exercise and Sale | 5,70 | 116,11k | - |
| 2026-03-31 | Mr. Matthew M. WalshExec. VP & CFO | 22,09k | 0,00 | Derivative Exercise and Retained Stock | - | 212,75k | 11,58% |
| 2026-03-31 | Mr. Matthew M. WalshExec. VP & CFO | -11,51k | 65,59k | Derivative Exercise and Sale | 5,70 | 212,75k | - |
| 2026-03-31 | Mr. Aaron FalcioneExec. VP & Chief HR Officer | 11,79k | 0,00 | Derivative Exercise and Retained Stock | - | 101,43k | 13,15% |
| 2026-03-31 | Mr. Aaron FalcioneExec. VP & Chief HR Officer | -6,14k | 35,00k | Derivative Exercise and Sale | 5,70 | 101,43k | - |
| 2026-03-31 | Mr. Kirke WeaverExec. VP, General Counsel & Corporate Secretary | 13,24k | 0,00 | Derivative Exercise and Retained Stock | - | 92,64k | 16,67% |
| 2026-03-31 | Mr. Kirke WeaverExec. VP, General Counsel & Corporate Secretary | -5,28k | 30,07k | Derivative Exercise and Sale | 5,70 | 92,64k | - |
| 2026-03-31 | Mr. Vittorio NisitaExec. VP and Head of Enterprise Services & Solutions | 8,55k | 0,00 | Derivative Exercise and Retained Stock | - | 70,62k | 13,77% |
| 2026-03-31 | Mr. Vittorio NisitaExec. VP and Head of Enterprise Services & Solutions | -4,45k | 25,38k | Derivative Exercise and Sale | 5,70 | 70,62k | - |
| 2026-03-31 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | 7,84k | 0,00 | Derivative Exercise and Retained Stock | - | 26,40k | 42,24% |
| 2026-03-31 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | -3,13k | 17,82k | Derivative Exercise and Sale | 5,70 | 26,40k | - |
| 2026-03-31 | Mr. Joseph T. MorrisseyCEO | 17,58k | 0,00 | Derivative Exercise and Retained Stock | - | 123,12k | 16,66% |
| 2026-03-31 | Mr. Joseph T. MorrisseyCEO | -7,01k | 39,93k | Derivative Exercise and Sale | 5,70 | 123,12k | - |
| 2026-03-29 | Ms. Rachel A. StahlerExec. VP, Chief Information Officer and Chief Digital & Growth Officer | 5,39k | 0,00 | Derivative Exercise and Retained Stock | - | 103,70k | 5,48% |
| 2026-03-29 | Ms. Rachel A. StahlerExec. VP, Chief Information Officer and Chief Digital & Growth Officer | -2,81k | 16,40k | Derivative Exercise and Sale | 5,84 | 103,70k | - |
| 2026-03-29 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | -1,52k | 8,85k | Derivative Exercise and Sale | 5,84 | 18,56k | - |
| 2026-03-29 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | 3,80k | 0,00 | Derivative Exercise and Retained Stock | - | 18,56k | 25,77% |
| 2026-03-29 | Mr. Daniel KarpChief Strategy Officer & Head of Corporate Development | -4,45k | 25,96k | Derivative Exercise and Sale | 5,84 | 57,15k | - |
| 2026-03-29 | Mr. Daniel KarpChief Strategy Officer & Head of Corporate Development | 9,74k | 0,00 | Derivative Exercise and Retained Stock | - | 57,15k | 20,54% |
| 2026-03-29 | Mr. Kirke WeaverExec. VP, General Counsel & Corporate Secretary | 5,55k | 0,00 | Derivative Exercise and Retained Stock | - | 79,40k | 7,51% |
| 2026-03-29 | Mr. Kirke WeaverExec. VP, General Counsel & Corporate Secretary | -2,21k | 12,91k | Derivative Exercise and Sale | 5,84 | 79,40k | - |
| 2026-03-29 | Mr. Vittorio NisitaExec. VP and Head of Enterprise Services & Solutions | 3,79k | 0,00 | Derivative Exercise and Retained Stock | - | 62,07k | 6,50% |
| 2026-03-29 | Mr. Vittorio NisitaExec. VP and Head of Enterprise Services & Solutions | -1,97k | 11,53k | Derivative Exercise and Sale | 5,84 | 62,07k | - |
| 2026-03-29 | Ms. Juliana Papa DrinaneHead of Manufacturing & Supply | 5,25k | 0,00 | Derivative Exercise and Retained Stock | - | 22,42k | 30,54% |
| 2026-03-29 | Ms. Juliana Papa DrinaneHead of Manufacturing & Supply | -2,73k | 15,96k | Derivative Exercise and Sale | 5,84 | 22,42k | - |
| 2026-03-29 | Dr. Juan Camilo Arjona FerreiraExec. VP, Head of Research & Development and Chief Medical Officer | -3,18k | 18,58k | Derivative Exercise and Sale | 5,84 | 21,44k | - |
| 2026-03-29 | Dr. Juan Camilo Arjona FerreiraExec. VP, Head of Research & Development and Chief Medical Officer | 5,68k | 0,00 | Derivative Exercise and Retained Stock | - | 21,44k | 36,08% |
| 2026-03-29 | Mr. Aaron FalcioneExec. VP & Chief HR Officer | 5,54k | 0,00 | Derivative Exercise and Retained Stock | - | 89,65k | 6,58% |
| 2026-03-29 | Mr. Aaron FalcioneExec. VP & Chief HR Officer | -2,89k | 16,85k | Derivative Exercise and Sale | 5,84 | 89,65k | - |
| 2026-03-29 | Mr. Matthew M. WalshExec. VP & CFO | 9,91k | 0,00 | Derivative Exercise and Retained Stock | - | 190,66k | 5,48% |
| 2026-03-29 | Mr. Matthew M. WalshExec. VP & CFO | -5,16k | 30,15k | Derivative Exercise and Sale | 5,84 | 190,66k | - |
| 2026-03-29 | Mr. Joseph T. MorrisseyCEO | 6,97k | 0,00 | Derivative Exercise and Retained Stock | - | 105,54k | 7,07% |
| 2026-03-29 | Mr. Joseph T. MorrisseyCEO | -2,78k | 16,23k | Derivative Exercise and Sale | 5,84 | 105,54k | - |
| 2026-02-27 | Mr. Aaron FalcioneExec. VP & Chief HR Officer | -11,01k | 79,05k | Sale to Issuer | 7,17 - 7,23 | 84,11k | -11,57% |
| 2026-02-27 | Mr. Matthew M. WalshExec. VP & CFO | -19,00k | 136,51k | Sale to Issuer | 7,17 - 7,23 | 180,75k | -9,51% |
| 2026-02-27 | Mr. Vittorio NisitaExec. VP and Head of Enterprise Services & Solutions | -7,79k | 55,91k | Sale to Issuer | 7,17 - 7,23 | 58,28k | -11,78% |
| 2026-02-27 | Ms. Rachel A. StahlerExec. VP, Chief Information Officer and Chief Digital & Growth Officer | -10,72k | 76,96k | Sale to Issuer | 7,17 - 7,23 | 98,31k | -9,83% |
| 2026-02-27 | Mr. Kirke WeaverExec. VP, General Counsel & Corporate Secretary | -8,58k | 61,61k | Sale to Issuer | 7,17 - 7,23 | 73,85k | -10,41% |
| 2026-02-27 | Mr. Joseph T. MorrisseyCEO | -10,27k | 73,77k | Sale to Issuer | 7,17 - 7,23 | 98,57k | -9,44% |
| 2025-11-07 | Ms. Juliana Papa DrinaneHead of Manufacturing & Supply | -1,24k | 8,33k | Sale to Issuer | 6,71 | 17,18k | -6,74% |
| 2025-11-12 | Ms. Carrie Smith CoxExecutive Chair of the Board | 65,40k | 501,76k | Kauf | 7,67 | 77,87k | 524,50% |
| 2025-11-07 | Ms. Juliana Papa DrinaneHead of Manufacturing & Supply | 3,63k | 0,00 | Derivative Exercise and Retained Stock | - | 17,18k | 26,76% |
| 2025-11-07 | Dr. Juan Camilo Arjona FerreiraExec. VP, Head of Research & Development and Chief Medical Officer | 4,14k | 0,00 | Derivative Exercise and Retained Stock | - | 28,92k | 16,71% |
| 2025-11-07 | Dr. Juan Camilo Arjona FerreiraExec. VP, Head of Research & Development and Chief Medical Officer | -2,31k | 15,48k | Derivative Exercise and Sale | 6,71 | 28,92k | - |
| 2025-11-07 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | 1,73k | 0,00 | Derivative Exercise and Retained Stock | - | 14,68k | 13,35% |
| 2025-11-07 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | -689,00 | 4,62k | Derivative Exercise and Sale | 6,71 | 14,68k | - |
| 2025-11-05 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | 2,17k | 0,00 | Derivative Exercise and Retained Stock | - | 12,95k | 20,14% |
| 2025-11-05 | Holzbaur LynetteSenior VP of Finance & Corporate Controller | -866,00 | 5,65k | Derivative Exercise and Sale | 6,52 | 12,95k | - |
| 2025-08-11 | Dr. Juan Camilo Arjona FerreiraExec. VP, Head of Research & Development and Chief Medical Officer | 7,40k | 0,00 | Derivative Exercise and Retained Stock | - | 24,78k | 42,56% |
| 2025-08-11 | Dr. Juan Camilo Arjona FerreiraExec. VP, Head of Research & Development and Chief Medical Officer | -4,12k | 38,00k | Derivative Exercise and Sale | 9,22 | 24,78k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
